Lupin Pursues India Approval For Lucentis Biosimilar, COVID-19 Opportunities

Favors Voluntary Licensing

 
• By Vibha Ravi
  
Lab Instruments
Lupin Seeks Approval For Lucentis Biosimilar In India As It Expands Product Pipeline • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business